ICP
Interchange Capital Partners Portfolio holdings
AUM
$433M
1-Year Return
16.43%
This Quarter Return
+3.64%
1 Year Return
+16.43%
3 Year Return
+67.58%
5 Year Return
–
10 Year Return
–
AUM
$276M
AUM Growth
-$5.77M
(-2.1%)
Cap. Flow
-$9.07M
Cap. Flow
% of AUM
-3.29%
Top 10 Holdings %
Top 10 Hldgs %
26.45%
Holding
276
New
15
Increased
59
Reduced
164
Closed
28
Top Buys
Top Sells
| 1 |
CVS Health
CVS
|
$861K |
| 2 |
iShares Core S&P 500 ETF
IVV
|
$785K |
| 3 |
JPMorgan Ultra-Short Income ETF
JPST
|
$551K |
| 4 |
Tesla
TSLA
|
$500K |
| 5 |
SPDR S&P Global Natural Resources ETF
GNR
|
$493K |
Sector Composition
| 1 | Technology | 16.2% |
| 2 | Financials | 7.5% |
| 3 | Healthcare | 7.02% |
| 4 | Consumer Discretionary | 6.92% |
| 5 | Communication Services | 5.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Vanguard Extended Market ETF
VXF
$24B
| $216K | 0.08% |
1,140
-4
| -0.3% | -$760 |
|
227
General Dynamics
GD
$86.7B
| $215K | 0.08% |
819
+78
| +11% | +$20.5K |
|
228
iShares US Home Construction ETF
ITB
$3.28B
| $215K | 0.08% |
2,075
+431
| +26% | +$44.6K |
|
|
TEM
229
Tempus AI, Inc. Class A Common Stock
TEM
$13.6B
| $214K | 0.08% |
+6,567
| New | +$214K |
|
230
Otis Worldwide
OTIS
$33.9B
| $210K | 0.08% |
2,267
| – | – |
|
231
Amphenol
APH
$138B
| $208K | 0.08% |
3,001
-447
| -13% | -$31K |
|
232
iShares Expanded Tech-Software Sector ETF
IGV
$9.73B
| $208K | 0.08% |
+2,076
| New | +$208K |
|
233
Honeywell
HON
$137B
| $206K | 0.07% |
+912
| New | +$206K |
|
234
iShares MSCI China ETF
MCHI
$7.78B
| $206K | 0.07% |
4,390
-1,232
| -22% | -$57.7K |
|
235
Recursion Pharmaceuticals
RXRX
$1.97B
| $202K | 0.07% |
30,823
-4,664
| -13% | -$30.6K |
|
236
Novartis
NVS
$249B
| $202K | 0.07% |
2,074
-93
| -4% | -$9.05K |
|
237
Lowe's Companies
LOW
$148B
| $201K | 0.07% |
815
-234
| -22% | -$57.8K |
|
238
Vanguard FTSE Europe ETF
VGK
$26.7B
| $200K | 0.07% |
3,159
+85
| +3% | +$5.39K |
|
239
SoFi Technologies
SOFI
$30.4B
| $189K | 0.07% |
12,246
-1,636
| -12% | -$25.2K |
|
240
10x Genomics
TXG
$1.69B
| $175K | 0.06% |
12,637
+14
| +0.1% | +$194 |
|
241
Gilead Sciences
GILD
$140B
| $172K | 0.06% |
1,858
| – | – |
|
242
Intellia Therapeutics
NTLA
$1.25B
| $163K | 0.06% |
14,451
-5,833
| -29% | -$65.9K |
|
243
iShares Silver Trust
SLV
$20B
| $160K | 0.06% |
6,082
-77
| -1% | -$2.03K |
|
244
Enbridge
ENB
$105B
| $156K | 0.06% |
+3,670
| New | +$156K |
|
245
Pacific Biosciences
PACB
$372M
| $52.9K | 0.02% |
29,996
+1,034
| +4% | +$1.83K |
|
246
Lloyds Banking Group
LYG
$65B
| $27.6K | 0.01% |
10,141
| – | – |
|
|
EXE
247
Expand Energy Corporation Common Stock
EXE
$23B
| $17.7K | 0.01% |
+178
| New | +$17.7K |
|
248
Actinium Pharmaceuticals
ATNM
$52.7M
| – | – |
-19,646
| Closed | -$36.9K |
|
249
AstraZeneca
AZN
$254B
| – | – |
-3,008
| Closed | -$235K |
|
|
250
CVS Health
CVS
$93.5B
| – | – |
-13,693
| Closed | -$861K |
|